Patients with respiratory allergies and allergic asthma, which are characterized by chronic type 2 airway inflammation, are often less susceptible to severe COVID-19. Lower viral replication is ...
Understanding how viral infection occurs can provide important clues for researchers to develop strategies to prevent viral transmission and develop effective therapeutic agents and vaccines. SARS-CoV ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), and it primarily infects cells in the respiratory tract. The human airway ...
Researchers have found that nasal ciliated cells are targeted at the onset of COVID-19 infection, which may open the potential to prevent infection by establishing nasal mucosal immunity. The COVID-19 ...
The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19 infection. Understanding how viral infection occurs can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback